Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-30

Clinical Trial Update: Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of double staining with Brilliant Blue G for macular surgery was terminated, involving patients with macular hol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brilliant Blue G (Brilliant Blue G)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Macular Hole, Epiretinal Membrane | Phase 3 | Status: TERMINATED